.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Cerilliant
Fish and Richardson
Baxter
Johnson and Johnson
US Department of Justice
Medtronic
QuintilesIMS
Accenture

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088292

« Back to Dashboard
NDA 088292 describes IMIPRAMINE HYDROCHLORIDE, which is a drug marketed by Sandoz, Leading Pharma Llc, Vangard, Watson Labs, Par Pharm, West Ward, Teva, Lupin Ltd, Sun Pharm Inds, Oxford Pharms, Novartis, Lederle, Usl Pharma, and Roxane, and is included in thirty-five NDAs. It is available from eighteen suppliers. Additional details are available on the IMIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

Summary for NDA: 088292

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 088292

Suppliers and Packaging for NDA: 088292

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
 TABLET;ORAL 088292 ANDA KAISER FOUNDATION HOSPITALS 0179-0118 0179-0118-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0118-70)
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
 TABLET;ORAL 088292 ANDA Par Pharmaceutical Inc. 49884-054 49884-054-01 100 TABLET in 1 BOTTLE (49884-054-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 21, 1983TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fuji
Accenture
Moodys
QuintilesIMS
Federal Trade Commission
Cerilliant
Dow
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot